EUVIMEDEUVIMED entdecken
Zurückgezogene PublikationOpen Access · CC BY 4.0

Exploratory algorithms to devise multi-epitope subunit vaccine by examining HIV-1 envelope glycoprotein: An immunoinformatics and viroinformatics approach

Saurav Kumar Mishra, Kanishka Sithira Senathilake, Neeraj Kumar, Chirag N Patel, Mohammad Borhan Uddin iD, Taha Alqahtani, Ali Alqahtani, Hanan M Alharbi, John J Georrge iD

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0318523 ↗

Kurz gefasst

Zurückgezogene Publikation in der Zeitschrift PLOS ONE, 2025. Verfasst von Saurav Kumar Mishra und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioinformatics, University of North Bengal, Darjeeling, West Bengal, India. Hauptthemen laut MEDLINE: HIV-1, AIDS Vaccines, Vaccines, Subunit, Algorithms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Scientific Research at King Khalid University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acquired immune deficiency syndrome (AIDS), a widespread pandemic and severe health issue, is triggered by the human immunodeficiency virus (HIV); there is no specific vaccine to cure this infection, and the situation is worsening. Therefore, this research sought to develop a vaccine with multiple epitopes against this infection targeting envelope glycoprotein (vital in host-cell interaction) through the immunoinformatics and viroinformatics approach. We identified one B-cell, eight MHC-I, and four MHC-II epitopes on its immunogen-assisted screening. In addition, these putative epitopes were conjoined concurrently using a specific linker (EAAAK, KK, GPGPG), including an adjuvant and a His-Tag at the N and C terminal, respectively, to augment its immune reaction. The final constructed entity consists of 284 amino acids; immunological evaluation demonstrated that the developed vaccine possesses antigenic features with a value of 0.6222, is non-allergenic, and has prospective physiochemical characteristics. The secondary and tertiary structures were anticipated, and their quality has been evaluated. Further, docking analysis between vaccines with TLR3 shows a strong molecular interaction with a -20.0 kcal/mol binding energy, and the stability was analysed through the MD simulation (100ns). Moreover, the designed vaccine expression and immune response were analysed, and a high vaccine expression level was found (pET28a (+)) and robust immune response followed by codon adaptation index value 0.94, 58.36% GC content, and the generation of IgM + IgG, cytokines and interleukin. Based on overall investigation, the developed vaccine stimulates a robust immune response. Nevertheless, laboratory analysis is needed to confirm the protective potency of the vaccine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1AIDS VaccinesVaccines, SubunitAlgorithmsenv Gene Products, Human Immunodeficiency VirusEpitopesHumansComputational BiologyMolecular Docking SimulationEpitopes, B-LymphocyteImmunoinformatics

Substanzen

AIDS VaccinesVaccines, Subunitenv Gene Products, Human Immunodeficiency VirusEpitopesEpitopes, B-Lymphocyte

Autor:innen und Institutionen

  • Department of Bioinformatics, University of North Bengal, Darjeeling, West Bengal, India.
  • Institute of Biochemistry, Molecular Biology and Biotechnology, University of Colombo, Colombo, Sri Lanka.
  • Department of Pharmaceutical Chemistry Bhupal Nobles, College of Pharmacy, Udaipur, Rajasthan, India.
  • Department of Botany, Bioinformatics and Climate Change Impacts Management, School of Science, Gujarat University, Ahmedabad, India.
  • Biotechnology Research Center, Technology Innovation Institute, Abu Dhabi, United Arab Emirates.
  • Computational Biology Research Laboratory, Department of Pharmacy, Faculty of Health and Life Sciences, Daffodil International University, Dhaka, Bangladesh.

ORCID-Profile: Mohammad Borhan Uddin, John J Georrge

Förderung

  • Deanship of Scientific Research at King Khalid University

Zitieren

APA

Mishra, S. K., Senathilake, K. S., Kumar, N., Patel, C. N., Uddin, M. B., Alqahtani, T., Alqahtani, A., Alharbi, H. M., & Georrge, J. J. (2025). Exploratory algorithms to devise multi-epitope subunit vaccine by examining HIV-1 envelope glycoprotein: An immunoinformatics and viroinformatics approach. PLOS ONE. https://doi.org/10.1371/journal.pone.0318523

Vancouver

Mishra SK, Senathilake KS, Kumar N, Patel CN, Uddin MB, Alqahtani T, et al. Exploratory algorithms to devise multi-epitope subunit vaccine by examining HIV-1 envelope glycoprotein: An immunoinformatics and viroinformatics approach. PLOS ONE. 2025. doi:10.1371/journal.pone.0318523

BibTeX
@article{Mishra2025,
  author = {Mishra, Saurav Kumar and Senathilake, Kanishka Sithira and Kumar, Neeraj and Patel, Chirag N and Uddin, Mohammad Borhan and Alqahtani, Taha and Alqahtani, Ali and Alharbi, Hanan M and Georrge, John J},
  title = {Exploratory algorithms to devise multi-epitope subunit vaccine by examining HIV-1 envelope glycoprotein: An immunoinformatics and viroinformatics approach},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0318523}
}
Kostenlos starten →